Daily Dose Newsletter

    0
    111

    The Daily Dose is a newsletter by Pro Pharma News, dedicated to bringing you the latest developments and insights from the pharmaceutical industry.


    🏥 Cigna and HealthEZ Unveil Cost-Reducing Solutions

    HealthEZ has announced a suite of new product solutions aimed at reducing costs for employers. Their exclusive network, Cigna OAP, offers discounts 4% better than standard PPO networks, promising significant savings for businesses.


    📈 AstraZeneca Expands Rare Disease Portfolio

    AstraZeneca has strengthened its position in the rare disease market with the acquisition of Amolyt Pharma. This move adds a Phase III therapeutic peptide candidate to their late-stage pipeline, promising advancements in rare disease treatments.


    💊 Moderna’s Stock Performance Update

    Moderna Inc. experienced a slight dip in stock value, closing $49.15 below its 52-week high. Despite the decline, Moderna continues to be a key player in the biotech industry.


    🏥 VCU Health Secures New Contracts with Aetna and Cigna

    VCU Health has signed multi-year agreements with Aetna and Cigna, ensuring continued in-network access for their patients. This strategic move strengthens their service offerings and patient reach.


    ⚖️ Vermont Sues CVS and Cigna for Inflating Drug Prices

    The state of Vermont, led by Attorney General Charity Clark, has filed a lawsuit against major pharmacy benefit managers CVS Health’s Caremark and Cigna Group’s PBM for allegedly inflating drug prices, raising significant legal and ethical questions.


    📊 Novartis Reports Strong Q2 Financial Results

    Novartis delivered impressive Q2 results with net sales up by 11% and core operating income margin approaching 40%. This strong performance underscores their continued growth and market strength.


    🏥 Catalent Expands Facility Capabilities in Germany

    Catalent Inc. has completed the expansion of its clinical supply facility in Schorndorf, Germany. This enhancement aims to bolster their clinical supply chain capabilities and meet growing global demand.


    🌿 Sanofi to Double Workforce by 2026

    Sanofi has announced plans to double its workforce at its Hyderabad Global Capability Center by 2026, expanding from 1,000 to 2,600 employees. This expansion will support their growing operations and innovation initiatives.


    That’s a wrap for today! Stay tuned for more updates and insights in the world of pharmaceuticals with The Daily Dose. Have a productive day!